These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8351229)

  • 1. [Atrial natriuretic peptide in rheumatic mitral valve disease].
    Hryniewiecki T; Rawczyńska-Englert I; Orłowska-Baranowska E; Pszona B
    Pol Arch Med Wewn; 1993 Apr; 89(4):293-7. PubMed ID: 8351229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin-converting enzyme inhibitors.
    Kula S; Tunaoglu FS; Olgunturk R; Gokcora N
    Can J Cardiol; 2003 Mar; 19(4):405-8. PubMed ID: 12704487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial diameter is a simple indicator of a deficiency in atrial natriuretic peptide secretion in patients with mitral stenosis: efficacy of postoperative supplementation with synthetic human alpha-atrial natriuretic peptide.
    Hayashi Y; Ohtani M; Sawa Y; Hiraishi T; Kobayashi Y; Matsuda H
    J Cardiovasc Pharmacol; 2004 Dec; 44(6):709-17. PubMed ID: 15550792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation.
    Kabukçu M; Arslantas E; Ates I; Demircioglu F; Ersel F
    Angiology; 2005; 56(2):159-63. PubMed ID: 15793605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between left atrial pressure and atrial natriuretic peptide in children with cardiac disease.
    Huang TY; Dai ZK; Wu JR; Huang MY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Apr; 11(4):197-204. PubMed ID: 7602654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma atrial natriuretic peptide is an early diagnosis and disease severity marker of myxomatous mitral valve disease in dogs.
    Ebisawa T; Ohta Y; Funayama M; Yamano S; Mizuno M; Mizuno T; Kasuya A; Sawada T; Lee J; Mizukoshi T; Uechi M
    Res Vet Sci; 2013 Jun; 94(3):717-21. PubMed ID: 23312500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of cardiac structure, blood flow velocity and heart function on circulating atrial natriuretic peptide and renin-angiotension system].
    Hua Q; Wang JR; Shi SY
    Zhonghua Nei Ke Za Zhi; 1994 Mar; 33(3):165-7. PubMed ID: 7805522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease.
    Gölbaşý Z; Uçar O; Yüksel AG; Gülel O; Aydoğdu S; Ulusoy V
    Eur J Heart Fail; 2004 Oct; 6(6):757-60. PubMed ID: 15542413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma atrial natriuretic peptide concentration in warmblood horses with heart valve regurgitations.
    Gehlen H; Sundermann T; Rohn K; Stadler P
    J Vet Cardiol; 2007 Nov; 9(2):99-101. PubMed ID: 18032122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of electrical cardioversion on left ventricular systolic function, left atrial size, ANP levels and enzymatic activity of CPK and CD-MB in serum of patients with paroxysmal atrial fibrillation].
    Spring A; Kosmala W; Mysiak A
    Przegl Lek; 1997; 54(9):585-90. PubMed ID: 9501676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure.
    Wozakowska-Kapłon B; Opolski G; Janion M; Kosior D
    Kardiol Pol; 2004 Dec; 61(12):513-21; discussion 522. PubMed ID: 15815752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation.
    Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S110-4. PubMed ID: 15683475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The concentration of atrial natriuretic peptide (ANP) in plasma and atrial tissue of canines with acute heart failure induced by reversible aortic or mitral regurgitation].
    Satoh K; Masuda T; Hasegawa N; Marumo F; Kikawada R
    Nihon Naibunpi Gakkai Zasshi; 1989 Aug; 65(8):794-806. PubMed ID: 2530121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
    Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
    J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the left ventricle in atrial natriuretic peptide secretion in acute mitral regurgitation.
    Satoh K; Masuda T; Masaki Y; Hasegawa N; Tsuyusaki T; Ando K; Marumo F; Kikawada R
    Am J Hypertens; 1990 Sep; 3(9):704-6. PubMed ID: 2145875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac hypertrophic risk markers of left ventricle and left atrium in chronic heart failure due to aortic and mitral valve disease.
    Jan MI; Khan RA; Khan N; Mahak A; Shah AUHA; Hussain ST; Kakakhel AU; Murtaza I
    Acta Radiol; 2021 May; 62(5):603-609. PubMed ID: 32571097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relations of intracardiac dimensions as measured by echocardiography and plasma atrial natriuretic peptide levels in various cardiovascular diseases].
    Tomoda H
    J Cardiol; 1989 Mar; 19(1):247-55. PubMed ID: 2530334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.